Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Brunet

Showing results (241-250 of 492) with videos related to

Pageof 50
Sort By:
Leukemia|May 25, 2004
Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantationD Gallardo, R De la Cámara, A Torres, et al.
Bone Marrow Transplantation|September 15, 2015
UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-identical sibling donor stem cell transplantationN Santos, R Rodríguez-Romanos, J B Nieto, et al.
Bone Marrow Transplantation|September 10, 2005
Long-term outcome of allogeneic PBSC transplantation in pediatric patients with hematological malignancies: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON) and the Spanish Group for Allogeneic Peripheral Blood Transplantation (GETH)M A Diaz, M Gonzalez-Vicent, M E Gonzalez, et al.
Leukemia|January 17, 2003
Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cellsL Muñoz, J F Nomdedéu, N Villamor, et al.
British Journal of Cancer|September 16, 1999
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutationsS Wang-Gohrke, W Weikel, H Risch, et al.
Bone Marrow Transplantation|January 13, 2015
Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximabI García-Cadenas, N Castillo, R Martino, et al.
American Journal of Human Genetics|March 31, 2000
BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancerR Moslehi, W Chu, B Karlan, et al.
Bone Marrow Transplantation|February 23, 2002
CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic TransplantationR Arranz, E Conde, F Rodriguez-Salvanés, et al.
Cancer Research|July 17, 2001
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive historyT R Rebbeck, Y Wang, P W Kantoff, et al.
Nature|December 8, 2006
A systems biology analysis of the Drosophila phagosomeL M Stuart, J Boulais, G M Charriere, et al.
Pageof 50

Showing results (241-250 of 492) with videos related to

Sort By:
Pageof 50
Leukemia|May 25, 2004
Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantationD Gallardo, R De la Cámara, A Torres, et al.
Bone Marrow Transplantation|September 15, 2015
UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-identical sibling donor stem cell transplantationN Santos, R Rodríguez-Romanos, J B Nieto, et al.
Bone Marrow Transplantation|September 10, 2005
Long-term outcome of allogeneic PBSC transplantation in pediatric patients with hematological malignancies: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON) and the Spanish Group for Allogeneic Peripheral Blood Transplantation (GETH)M A Diaz, M Gonzalez-Vicent, M E Gonzalez, et al.
Leukemia|January 17, 2003
Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cellsL Muñoz, J F Nomdedéu, N Villamor, et al.
British Journal of Cancer|September 16, 1999
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutationsS Wang-Gohrke, W Weikel, H Risch, et al.
Bone Marrow Transplantation|January 13, 2015
Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximabI García-Cadenas, N Castillo, R Martino, et al.
American Journal of Human Genetics|March 31, 2000
BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancerR Moslehi, W Chu, B Karlan, et al.
Bone Marrow Transplantation|February 23, 2002
CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic TransplantationR Arranz, E Conde, F Rodriguez-Salvanés, et al.
Cancer Research|July 17, 2001
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive historyT R Rebbeck, Y Wang, P W Kantoff, et al.
Nature|December 8, 2006
A systems biology analysis of the Drosophila phagosomeL M Stuart, J Boulais, G M Charriere, et al.
Pageof 50